Neuropsychiatric symptoms (NPS) are common in hereditary ataxias as a part of the cerebellar cognitive affective syndrome. In Friedreich ataxia (FRDA), one of the most common hereditary ataxias, depressive symptoms were previously reported, but little is known about other NPS. We aimed to study the presence and severity of a broad range of NPS in individuals with FRDA and assess the relationship between the NPS and the disease severity, cognition, and quality of life and to examine the concordance between the NPS reported by the patients and by their informants. Mild Behavioral Impairment Checklist (MBI-C), a questionnaire designed for screening NPS in the early stages of neurodegenerative diseases, was administered to informants of individuals with FRDA and healthy controls and to people with FRDA themselves. Compared to healthy controls, patients with FRDA scored significantly higher in the total MBI-C score, emotion dysregulation domain (corresponding to depression and anxiety), and decreased motivation domain. When assessed by caregiver, the total MBI-C score and several NPS domains correlated with activities of daily living. Only psychotic symptoms were related to ataxia severity and general cognition. When endorsed by patients, only the relation between few MBI-C domains and quality of life was observed. We found slight to moderate agreement between informant-rated and patient-rated scores. NPS, particularly emotion dysregulation and decreased motivation, are common and clinically relevant in FRDA and should receive more attention due to their potential impact on quality of life and the possibility of therapeutic intervention.

Center of Hereditary Ataxias Department of Neurology 2nd Faculty of Medicine and Motol University Hospital Charles University Prague Czech Republic

Center of Hereditary Ataxias Department of Pediatric Neurology 2nd Faculty of Medicine and Motol University Hospital Charles University Prague Czech Republic

Edson College of Nursing and Health Innovation Arizona State University Phoenix AZ USA

Women's Operational Military Exposure Network Center of Excellence VA Palo Alto Health Care System Palo Alto CA USA

See more in PubMed

Schmahmann, J. The cerebellar cognitive affective syndrome. Brain121, 561–579 (1998). PubMed

Argyropoulos, G. P. D. et al. The cerebellar cognitive affective/schmahmann syndrome: A task force paper. Cerebellum vol. 19 102–125 Preprint at (2020). 10.1007/s12311-019-01068-8 PubMed PMC

Abderrakib, A., Ligot, N. & Naeije, G. Cerebellar cognitive affective syndrome after acute cerebellar stroke. Front. Neurol.13, (2022). PubMed PMC

Levisohn, L., Cronin-Golomb, A. & Schmahmann, J. D. Neuropsychological consequences of cerebellar tumour resection in children. Brain123, 1041–1050 (2000). PubMed

Kronemer, S. I. et al. Neuropsychiatric symptoms as a reliable phenomenology of cerebellar ataxia. Cerebellum20, 141–150 (2021). PubMed PMC

Cook, A. & Giunti, P. Friedreich’s ataxia: Clinical features, pathogenesis and management. British Medical Bulletin vol. 124 19–30 Preprint at (2017). 10.1093/bmb/ldx034 PubMed PMC

Nieto, A. et al. Cognition in Friedreich Ataxia. Cerebellum11, 834–844 (2012). PubMed

Mantovan, M. C. et al. Exploring mental status in Friedreich’s ataxia: A combined neuropsychological, behavioral and neuroimaging study. European Journal of Neurology vol. 13 827–835 Preprint at (2006). 10.1111/j.1468-1331.2006.01363.x PubMed

Sayah, S. et al. Personality and neuropsychological profiles in Friedreich ataxia. Cerebellum17, 204–212 (2018). PubMed

Schmahmann, J. D., Pierce, S., MacMore, J. & L’Italien, G. J. Development and validation of a patient-reported outcome measure of Ataxia. Mov. Disord.10.1002/mds.28670 (2021). PubMed

Schmitz-Hübsch, T. et al. Depression comorbidity in spinocerebellar ataxia. Mov. Disord.26, 870–876 (2011). PubMed

von Eichel, H. et al. Neuropsychiatric symptoms in Parkinson’s Disease patients are Associated with reduced health-related quality of life and increased caregiver Burden. Brain Sci.12, (2022). PubMed PMC

Karttunen, K. et al. Neuropsychiatric symptoms and quality of life in patients with very mild and mild Alzheimer’s disease. Int. J. Geriatr. Psychiatry. 26, 473–482 (2011). PubMed

Chan, Y. C. Aripiprazole treatment for psychosis associated with Friedreich’s ataxia. Gen. Hosp. Psychiatry. 27, 372 (2005). PubMed

Oruc, S., Gulseren, G., Kusbeci, O. Y., Yaman, M. & Gecici, O. Quetiapine treatment for psychosis in Friedreich’s ataxia. Klinik Psikofarmakoloji Bülteni-Bulletin Clin. Psychopharmacol.22, 357–358 (2012).

Salbenblatt, M. J., Buzan, R. D. & Dubovsky, S. L. Risperidone treatment for psychosis in end-stage Friedreich’s ataxia. Am. J. Psychiatry. 157, 303 (2000). PubMed

Corben, L. A. et al. Clinical management guidelines for Friedreich ataxia: best practice in rare diseases. Orphanet J. Rare Dis.17, 415 (2022). PubMed PMC

Pérez-Flores, J., Hernández-Torres, A., Montón, F. & Nieto, A. Health-related quality of life and depressive symptoms in Friedreich ataxia. Qual. Life Res.29, 413–420 (2020). PubMed

Nieto, A., Hernández-Torres, A., Pérez-Flores, J. & Montón, F. Depressive symptoms in Friedreich ataxia. Int. J. Clin. Health Psychol.18, 18–26 (2018). PubMed PMC

da Silva, C. B., Chevis, C. F., D’Abreu, A., Lopes-Cendes, I. & França, M. C. Fatigue is frequent and multifactorial in Friedreich’s ataxia. Parkinsonism and Related Disorders vol. 19 766–767 Preprint at (2013). 10.1016/j.parkreldis.2013.04.007 PubMed

Dogan, I. et al. Cognition in Friedreich’s ataxia: a behavioral and multimodal imaging study. Ann. Clin. Transl Neurol.3, 572–587 (2016). PubMed PMC

Hernández-Torres, A., Montón, F., Medler, H., De Nóbrega, S., Nieto, A. & É. & Longitudinal study of cognitive functioning in Friedreich’s Ataxia. J. Int. Neuropsychol. Soc.27, 343–350 (2021). PubMed

Costabile, T. et al. Emotion recognition and psychological comorbidity in Friedreich’s ataxia. Cerebellum17, 336–345 (2018). PubMed

White, M., Lalonde, R. & Botez-Marquard, T. Neuropsychologic and neuropsychiatric characteristics of patients with Friedreich’s ataxia. Acta Neurol. Scand.102, 222–226 (2000). PubMed

Ganos, C., Schöttle, D., Zühlke, C. & Münchau, A. Psychosis complicating Friedreich Ataxia. Mov. Disord Clin. Pract.2, 84–85 (2015). PubMed PMC

Zalesky, A. et al. Cerebello-cerebral connectivity deficits in Friedreich ataxia. Brain Struct. Funct.219, 969–981 (2014). PubMed

Cummings, J. L. The neuropsychiatric inventory: Assessing psychopathology in dementia patients. Neurology48, 10S–16S (1997). PubMed

Kaufer, D. I. et al. Validation of the NPI-Q, a brief clinical form of the neuropsychiatric inventory. J. Neuropsychiatry Clin. Neurosci.12, 233–239 (2000). PubMed

Ismail, Z. et al. The mild behavioral impairment checklist (MBI-C): A rating scale for neuropsychiatric symptoms in Pre-dementia populations. J. Alzheimer’s Disease. 56, 929–938 (2017). PubMed PMC

Ismail, Z. et al. Neuropsychiatric symptoms as early manifestations of emergent dementia: Provisional diagnostic criteria for mild behavioral impairment. Alzheimer’s Dement.12, 195–202 (2016). PubMed PMC

Mallo, S. C. et al. Assessing mild behavioral impairment with the mild behavioral impairment-checklist in people with mild cognitive impairment. J. Alzheimer’s Disease. 66, 83–95 (2018). PubMed

Lang, S. et al. Mild behavioral impairment in Parkinson’s disease is associated with altered corticostriatal connectivity. Neuroimage Clin.26, (2020). PubMed PMC

Yoon, E. J. et al. Mild behavioral impairment is linked to worse cognition and brain atrophy in Parkinson disease. Neurology93, e766–e777 (2019). PubMed PMC

Ramezani, M. et al. Association between BDNF Val66Met polymorphism and mild behavioral impairment in patients with Parkinson’s disease. Front. Neurol.11, (2021). PubMed PMC

Ferraro, P. M. et al. Mild behavioral impairment as a potential marker of predementia risk states in motor neuron diseases. Eur. J. Neurol.30, 47–56 (2023). PubMed PMC

Ismail, Z. MBI test. Retrieved from https://mbitest.org/

McKinlay, A. et al. Neuropsychiatric problems in Parkinson’s disease: Comparisons between self and caregiver report. Aging Ment Health. 12, 647–653 (2008). PubMed

Muller, A. J. et al. Informant- and self-appraisals on the psychosis and Hallucinations Questionnaire (PsycH-Q) enhances detection of visual hallucinations in Parkinson’s Disease. Mov. Disord. Clin. Pract.5, 607–613 (2018). PubMed PMC

Schmitz-Hübsch, T. et al. Scale for the assessment and rating of ataxia. Neurology66, 1717–1720 (2006). PubMed

Nasreddine, Z. S. et al. The montreal cognitive assessment, MoCA: A brief screening tool for mild cognitive impairment. J. Am. Geriatr. Soc.53, 695–699 (2005). PubMed

Bürk, K., Schulz, S. R. & Schulz, J. B. Monitoring progression in Friedreich ataxia: the use of clinical scales. J. Neurochem. 126, 118–124 (2013). PubMed

Herdman, M. et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual. Life Res.20, 1727–1736 (2011). PubMed PMC

Matušková, V. et al. Neuropsychiatric symptoms as early manifestation of Alzheimer’s disease. Česká slovenská Neurologie Neurochirurgie. 83/116, 64–72 (2020).

RStudio, T. & RStudio RStudio: Integrated Development for R. PBC, Boston, MA URL http://www.rstudio.com/. (2020).

Reetz, K. et al. Nonataxia symptoms in Friedreich Ataxia: Report from the Registry of the European Friedreich’s Ataxia Consortium for Translational studies (EFACTS). Neurology91, e917–e930 (2018). PubMed

Fichera, M. et al. Comorbidities in Friedreich ataxia: incidence and manifestations from early to advanced disease stages. Neurol. Sci.43, 6831–6838 (2022). PubMed

Schneider, R. B., Iourinets, J. & Richard, I. H. Parkinson’s disease psychosis: Presentation, diagnosis and management. Neurodegener Dis. Manag. 7, 365–376 (2017). PubMed

Matuskova, V. et al. Comparison between self- and informant‐rated versions of the mild behavioral impairment checklist in patients with mild cognitive impairment. Alzheimer’s Dement.19, (2023).

Karamazovova, S., Matuskova, V., Ismail, Z. & Vyhnalek, M. Neuropsychiatric symptoms in spinocerebellar ataxias and Friedreich ataxia. Neurosci. Biobehav Rev.150, 105205 (2023). PubMed

Fancellu, R. et al. Longitudinal study of cognitive and psychiatric functions in spinocerebellar ataxia types 1 and 2. J. Neurol.260, 3134–3143 (2013). PubMed

Moriarty, A. et al. A longitudinal investigation into cognition and disease progression in spinocerebellar ataxia types 1, 2, 3, 6, and 7. Orphanet J. Rare Dis.11, (2016). PubMed PMC

Lo, R. Y. et al. Depression and clinical progression in spinocerebellar ataxias. Parkinsonism Relat. Disord. 22, 87–92 (2016). PubMed PMC